| Net Cash Provided by (Used in) Operating Activities |
-72,494,000 |
USD |
-5.3% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
83,578,000 |
USD |
+14.4% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
450,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
47,268,027 |
shares |
-41.2% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
11,084,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
18,081,000 |
USD |
-63% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
7,189,000 |
USD |
+8.4% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
| Deferred Tax Assets, Gross |
10,054,000 |
USD |
-2.4% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
-6,347,000 |
USD |
-3.4% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
32,000 |
USD |
-95.2% |
Q4 2024 |
FY 2024 |
| Deferred Federal Income Tax Expense (Benefit) |
-5,337,000 |
USD |
-2.5% |
Q1 2025 |
Q1 2025 |
| Current Income Tax Expense (Benefit) |
5,143,000 |
USD |
+4.8% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
791,191,000 |
USD |
+14.7% |
Q3 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
633,000 |
USD |
+71.1% |
Q1 2025 |
Q1 2025 |
| Current Federal Tax Expense (Benefit) |
3,543,000 |
USD |
+79.5% |
Q1 2025 |
Q1 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
-1,010,000 |
USD |
-23.6% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
37,673,000 |
USD |
+33.5% |
Q1 2024 |
Q1 2024 |